SM was significantly associated with higher biopsy Gleason scores, higher clinical T stage, higher PSA level at diagnosis, and were more likely to have high-burden metastasis and lymph node metastasis. The gene discussed is KLK3; the disease is metastatic malignant neoplasm in the lymph nodes.